Events & Presentations
May 20, 15:30 – 17:30 | Biomed Israel 2025
Kevin Slawin, MD, Founder and CEO, Eos SENOLYTIX
Novel Gerotherapeutic Peptide PTC-2105 Demonstrates Features of a Safe and Effective Gerotherapeutic in Aged Mice
14 November 2024 | 12:30 PM GMT/7:30 AM EST| Online
Kevin Slawin, MD, Founder and CEO, Eos SENOLYTIX
February 27-28, 2025
Kevin Slawin, MD, Founder and CEO, Eos SENOLYTIX
March 12, 2025
Kevin Slawin, MD, Founder and CEO, Eos SENOLYTIX
March 14, 2025 | Toulouse, FR
Kevin Slawin, MD, Founder and CEO, Eos SENOLYTIX
June 10-11, 2024 | London, England
Kevin Slawin, MD, Founder and CEO, Eos SENOLYTIX
© 2025 Eos SENOLYTIX.